This page contains a Flash digital edition of a book.
BIO
TECHNOLOGY
Biotechnology
- a booming
sector
India is becoming a global player in biotechnology
and offers huge opportunities for strategic
partnerships and investment.
tremendous growth
Biotechnology is a fast emerging sector in India and the
Biotech Industry is experiencing a tremendous growth
rate of nearly 40 per cent, with the annual turnover in
2005 being A$1.22 billion. The consumption of biotech
products in India is expected to grow to the tune of
A$4,866 million by 2010.
FaSt Fact:
According to Ernst & Young, India is one of the five
Key success factors
emerging biotech leaders in the Pacific besides
Singapore, Taiwan, Japan and Korea with mainland
The key success factors for India in the biotech industry
China catching up quickly. The study ranked India
are:
third in the region based on the number of biotech
l A large and strong pool of qualified scientists and companies in the country after Australia and China
engineers, including non-resident Indians who
(including Hong Kong).
provide a pool of experienced specialists;
l Existing and upcoming research facilities and
institutional networks; support in the form of incentives given at both state and
l A traditional and significant presence in the central levels (Federal and Provincial). All of these factors
production of generics; and are encouraging foreign investment to enjoy the benefits
l India has an extremely diverse species of flora and and advantages of operating in this emerging market.
fauna that gives the added advantage for biotech
companies to carry on their research and drug
Substantial research collaborations
discovery effectively. In 2006, the Australian Government took a major step
Another important factor for the growth of the Indian forward, together with the Indian Central Government in
Biotech industry is strong and committed government establishing the Australia-India Strategic Research Fund.
Each government committed to provide A$20 million
indian biotech StatiSticS
over five years for collaborative research projects in areas
such as transgenic crops, stem cell therapies, plant
l The human health biotech products account
neutraceuticals, nanotechnology and bioremediation.
for 60% of the total market; agribiotech and
veterinary 25%; medical devices, contract research
Last year an agreement was signed at India’s major
and development (R&D), reagents and supplies biotechnology conference, Bio Bangalore, between
constitute the remaining 15%.
Australia’s Deakin University and Biocon – India’s largest
l Growth in the pharmaceutical industry is expected
to bring in revenues of A$5.13 billion with the
biotechnology company. This led to the establishment
industry growing at around 8-9% each year.
of a Deakin Research Institute in Bangalore. It also
l The increasing numbers of Contract Research sought to develop a business case to jointly bid for a
Organisations (CROs) are evidence to the
A$10 million Australian Government grant to develop
opportunity and growth in the market. The CRO
market in India is worth A$284.9 million and is
a mammalian cell bioprocessing facility at Deakin’s
growing at 30-40% year on year. Geelong Technology Precinct.
l Ranked fourth globally in terms of volume and 13th
There are also a significant number of research
in terms of value, India has the highest number
collaborations between Australian and Indian universities,
of manufacturing plants approved by the United
States Food and Drug Administration (USFDA)
including programs at The University of Melbourne,
outside the USA. Monash University, Queensland’s University of Technology
and the Queensland Institute of Medical Research.
INVEST IN AUSTRALIA – INDIA 83
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108
Produced with Yudu - www.yudu.com